Omeros Corp. (OMER) PT Lowered to $22 at Needham & Company Following 4Q Report; 'OMS721 Ph3 Trial Now Underway'
Tweet Send to a Friend
Needham & Company analyst Serge Belanger lowered its price target on Omeros Corp. (NASDAQ: OMER) to $22.00 (from $24.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
